ANIXA BIOSCIENCES INC - 41 Year Stock Price History | ANIX

The latest closing stock price for ANIXA BIOSCIENCES INC as of April 29, 2025 is 2.75.

  • An investor who bought $1,000 worth of ANIXA BIOSCIENCES INC stock at the IPO in 1984 would have $-948 today, roughly -1 times their original investment - a -7.13% compound annual growth rate over 40 years.
  • The all-time high ANIXA BIOSCIENCES INC stock closing price was 242.19 on June 13, 1996.
  • The ANIXA BIOSCIENCES INC 52-week high stock price is 4.20, which is 52.7% above the current share price.
  • The ANIXA BIOSCIENCES INC 52-week low stock price is 2.07, which is 24.7% below the current share price.
  • The average ANIXA BIOSCIENCES INC stock price for the last 52 weeks is 2.93.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.

ANIXA BIOSCIENCES INC - 41 Year Stock Price History | ANIX

  • An investor who bought $1,000 worth of ANIXA BIOSCIENCES INC stock at the IPO in 1984 would have $-948 today, roughly -1 times their original investment - a -7.13% compound annual growth rate over 40 years.
  • The all-time high ANIXA BIOSCIENCES INC stock closing price was 242.19 on June 13, 1996.
  • The ANIXA BIOSCIENCES INC 52-week high stock price is 4.20, which is 52.7% above the current share price.
  • The ANIXA BIOSCIENCES INC 52-week low stock price is 2.07, which is 24.7% below the current share price.
  • The average ANIXA BIOSCIENCES INC stock price for the last 52 weeks is 2.93.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Related Stocks
Company NameMarket
Cap
AstraZeneca (AZN)$209.6B
Amgen (AMGN)$149.1B
Gilead Sciences (GILD)$130.2B
Vertex Pharmaceuticals (VRTX)$125.6B
Bristol Myers Squibb (BMY)$100.2B
CSL (CSLLY)$74.3B
GSK (GSK)$74.1B
Regeneron Pharmaceuticals (REGN)$61.6B
Argenex SE (ARGX)$36.2B
Alnylam Pharmaceuticals (ALNY)$30.5B
BioNTech SE (BNTX)$23.7B
BeiGene (ONC)$22.8B
Biogen (BIIB)$17.4B
Genmab (GMAB)$13.3B
Genmab (GNMSF)$13.3B
Insmed (INSM)$13.2B
BioMarin Pharmaceutical (BMRN)$11.3B
Illumina (ILMN)$11.3B
Incyte (INCY)$11.3B
Ascendis Pharma (ASND)$10.1B
Exelixis (EXEL)$10B
Swedish Orphan Biovitrum (BIOVF)$9.6B
Moderna (MRNA)$9.6B
QIAGEN (QGEN)$9B
Exact Sciences (EXAS)$7.7B
Bio-Techne Corp (TECH)$7.6B
Repligen (RGEN)$7.3B
Halozyme Therapeutics (HALO)$7.3B
Roivant Sciences (ROIV)$7.2B
Revolution Medicines (RVMD)$6.8B